ArticleMethods in molecular biology (Clifton, N.J.)2026
Recombinant Production and Characterization of Human Enzymes Responsible for Collagen Lysine Post-translational Modifications.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biosynthesis of collagen molecules, as well as collagenous segments of non-collagen proteins, requires extensive post-translational modifications (PTMs) that confer specific functional and structural properties to tissues and organs. Within collagen polypeptide sequences, lysine residues are subject to a series of PTMs, resulting in hydroxylation and subsequent O-linked glycosylation of their side chains. These modifications are catalyzed by two distinct metalloenzyme families, named LH/PLOD and GLT25D/COLGALT, which alternatively process modified lysine side chains yielding 5-hydroxylysine (LH/PLOD), β-(1,O)-galactosyl-5-hydroxylysine (GLT25D/COLGALT), and α-(1,2)-glucosyl-β-(1,O)-galactosyl-5-hydroxylysine (LH/PLOD). In this chapter, we illustrate strategies to recombinantly produce human full-length LH3/PLOD3 as well as GLT25D1/COLGALT1, verify the quality of these recombinant preparations, and perform direct and indirect assays to evaluate their enzymatic activities in vitro on synthetic collagen peptides and gelatin.
Indexed as
Identifiers
42681151What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.